Paradromics Appoints William J. Marks, Jr., MD, MS-HCM, as Chief Clinical Officer
AI Briefing
- • Paradromics appoints William J. Marks, Jr., MD, MS-HCM, as Chief Clinical Officer.
- • Dr. Marks has nearly three decades of experience in clinical neuroscience and implantable medical devices.
- • He will lead clinical efforts for Paradromics' brain-computer interface platform.
Source Summary
AUSTIN, Texas--(BUSINESS WIRE)--Paradromics Inc., a leader in neurotechnology and developer of the world’s highest-data-rate brain-computer interface platform to restore human function and advance human capability, today announced the appointment of William J. Marks, Jr., MD, MS-HCM, as Chief Clinical Officer. Dr. Marks is a neurologist and clinical scientist with nearly three decades of experience across clinical neuroscience, implantable medical devices, neuromodulation, and digital health. D
Advertisement